Results
eNauka >
Results >
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial
![](https://cdn3.iconfinder.com/data/icons/flat-actions-icons-9/512/Tick_Mark-256.png)
Title: | Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial | Authors ![]() | Dimopoulos, Meletios Athanasios; ...; Bila, Jelena S. ![]() ![]() |
Issue Date: | 2021 | Publication: | The Lancet. Oncology | ISSN: | 1470-2045![]() ![]() |
Publisher: | London : Lancet Pub. Group | Type: | Article | Collation: | vol. 22 br. 6 str. 801-812 | DOI: | 10.1016/S1470-2045(21)00128-5 | WoS-ID: | 000657432100048 | Scopus-ID: | 2-s2.0-85107139896 | PMID: | 34087126 | URI: | https://enauka.gov.rs/handle/123456789/822958 | URL: | https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(21)00128-5/abstract | Project: | European Myeloma Network Janssen Research and Development |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21aM21a |
![](/image/scopus.png)
SCOPUSTM
![](/image/pubmed.png)
PubMed CentralTM
![](/image/wos.png)
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.